Novanta Inc Stock Price, News & Analysis

Novanta Inc. (NASDAQ: NOVT) will release its third quarter 2022 results on November 8, 2022. A conference call is scheduled for 10:00 a.m. ET on the same day, which can be accessed by dialing (888) 346-3959 or through a live webcast on the company's website. The audio replay of the call will be available for listening approximately three hours post-event until January 2, 2023. Novanta specializes in advanced technology solutions for medical and industrial OEMs, focusing on precision and performance.

Novanta reported a strong second quarter in 2022 with GAAP revenue of $215.4 million, a 29% increase year-over-year. Consolidated net income reached $17.5 million, reflecting a 49% rise in diluted EPS to $0.49. Adjusted EPS improved by 26% to $0.78, while adjusted EBITDA was $45.0 million. With bookings up 25% year-over-year, the company raised its full-year guidance, forecasting revenue between $848 million and $852 million.

Novanta Inc. (NASDAQ: NOVT) will release its second quarter 2022 results on August 9, 2022, followed by a conference call at 10:00 a.m. ET. Interested parties can access the call by dialing (888) 346-3959 or through a live webcast on the company’s website. A replay will be available approximately three hours post-call and will remain accessible until October 3, 2022. As a leader in technology solutions for healthcare and advanced industries, Novanta enables OEMs with precision and performance in their applications.

Novanta Inc. (NASDAQ: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on July 12, 2022, in Greenwich, CT. As a leading supplier of technology solutions for medical and advanced industrial OEMs, Novanta focuses on precision technology, including photonics and motion control. The company emphasizes innovation and customer success, aiming to provide a competitive edge to its partners. For more details, visit www.novanta.com.

Novanta Inc. (Nasdaq: NOVT) announced that CFO Robert Buckley will present at Baird's 2022 Global Consumer, Technology & Services Conference on June 7, 2022, in New York, NY. Novanta is a leader in providing technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. Their expertise enables them to deliver high-performance core components tailored to demanding applications. For more information, visit www.novanta.com.

Novanta Inc. (NASDAQ: NOVT) announces that CFO Robert Buckley and EVP Charlie Webster will present at the William Blair 42nd Annual Growth Stock Conference on June 6, 2022, in Chicago, IL. The company is a leading global supplier of technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. With a commitment to innovation and customer success, Novanta engineers components that deliver precision performance tailored to demanding applications.

Novanta reported a strong first quarter 2022, with GAAP revenue rising 26% to $204 million and net income of $18.8 million. Adjusted EPS increased 26% to $0.73, while Adjusted EBITDA grew 33% to $43.6 million. Customer demand remains robust, with a record backlog of $586 million and an organic revenue growth of 7.4%. Novanta expects continued strong growth in Q2 2022, with revenue guidance of $205 million to $213 million despite macroeconomic challenges.

Celera Motion, a unit of Novanta, announced new sizes and capabilities for its Aura Absolute Chip Encoder Series. These encoders cater to high-volume OEM applications such as surgical robots and cobots. The Aura line features built-in eccentricity compensation, high resolution, and low-power consumption. New customizable scale sizes range from 18 mm to 63.5 mm for rotary and 9 mm to 195 mm for linear applications. This expansion aims to enhance precision in motion-control solutions while addressing customer demands for high performance.

Novanta Inc. (NASDAQ: NOVT) will release its first quarter 2022 results on May 10, 2022. A conference call is scheduled for 10:00 a.m. ET the same day, available via dial-in or live webcast on Novanta's investor relations page. The call will provide insights into the company's performance and strategic direction. A replay of the call will be accessible three hours afterward and will remain available until July 4, 2022. Novanta specializes in technology solutions for healthcare and advanced industrial OEMs, focusing on photonics, vision, and precision motion.